USANA Health Sciences (USNA) Reaches New 1-Year High and Low at $97.85

Shares of USANA Health Sciences, Inc. (NYSE:USNA) hit a new 52-week high and low on Monday . The company traded as low as $97.85 and last traded at $98.30, with a volume of 67291 shares changing hands. The stock had previously closed at $96.55.

USNA has been the subject of a number of research reports. Sidoti downgraded shares of USANA Health Sciences from a “buy” rating to a “neutral” rating in a report on Wednesday, January 24th. TheStreet downgraded shares of USANA Health Sciences from a “b+” rating to a “c+” rating in a report on Tuesday, February 6th. Finally, Pivotal Research increased their price target on shares of USANA Health Sciences from $80.00 to $95.00 and gave the company a “buy” rating in a report on Wednesday, February 7th.

How to Become a New Pot Stock Millionaire

The firm has a market cap of $2,321.97, a price-to-earnings ratio of 24.31 and a beta of 0.81.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings data on Tuesday, February 6th. The company reported $1.11 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.11. The company had revenue of $273.11 million during the quarter, compared to the consensus estimate of $258.67 million. USANA Health Sciences had a net margin of 5.97% and a return on equity of 27.08%. The firm’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same period last year, the firm earned $0.87 EPS. analysts predict that USANA Health Sciences, Inc. will post 4.25 EPS for the current fiscal year.

In other news, Director Myron W. Wentz sold 78,129 shares of the firm’s stock in a transaction dated Friday, March 9th. The shares were sold at an average price of $81.19, for a total transaction of $6,343,293.51. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, major shareholder Global Ltd Gull sold 2,753 shares of the firm’s stock in a transaction dated Friday, February 2nd. The stock was sold at an average price of $74.24, for a total transaction of $204,382.72. Following the transaction, the insider now directly owns 11,682,053 shares of the company’s stock, valued at $867,275,614.72. The disclosure for this sale can be found here. Insiders have sold a total of 729,767 shares of company stock valued at $58,024,833 over the last ninety days. 48.00% of the stock is owned by insiders.

Several large investors have recently added to or reduced their stakes in the company. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp lifted its holdings in shares of USANA Health Sciences by 180.4% during the 4th quarter. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp now owns 45,700 shares of the company’s stock worth $3,384,000 after acquiring an additional 29,400 shares during the period. MetLife Investment Advisors LLC bought a new position in shares of USANA Health Sciences during the 4th quarter worth about $415,000. Macquarie Group Ltd. bought a new position in USANA Health Sciences during the 4th quarter valued at about $298,000. PEAK6 Investments L.P. bought a new position in USANA Health Sciences during the 4th quarter valued at about $657,000. Finally, Cornerstone Capital Management Holdings LLC. lifted its holdings in USANA Health Sciences by 83.9% during the 4th quarter. Cornerstone Capital Management Holdings LLC. now owns 60,700 shares of the company’s stock valued at $4,494,000 after purchasing an additional 27,700 shares during the last quarter. 48.28% of the stock is owned by institutional investors.

TRADEMARK VIOLATION WARNING: This report was first posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this report can be viewed at https://www.chaffeybreeze.com/2018/04/16/usana-health-sciences-usna-reaches-new-1-year-high-and-low-at-97-85.html.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply